281 related articles for article (PubMed ID: 17695464)
81. Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy.
Feliu J; Calvilio J; Escribano A; de Castro J; Sánchez ME; Mata A; Espinosa E; García Grande A; Mateo A; González Barón M
Ann Oncol; 2002 May; 13(5):730-6. PubMed ID: 12075741
[TBL] [Abstract][Full Text] [Related]
82. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
[TBL] [Abstract][Full Text] [Related]
83. [Two metastatic colonic cancer patients successfully treated by combination therapy of tegafur/uracil (UFT) and oral Leucovorin].
Ina K; Kataoka T; Ohkita T; Nagao S; Ito A; Inagaki J; Kato H; Ando T; Niwa Y; Goto H
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1469-71. PubMed ID: 17033240
[TBL] [Abstract][Full Text] [Related]
84. Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies.
Passardi A; Maltoni R; Milandri C; Cecconetto L; Massa I; Zoli W; Tesei A; Fabbri F; Nanni O; Amadori D
Oncology; 2007; 72(1-2):118-24. PubMed ID: 18004083
[TBL] [Abstract][Full Text] [Related]
85. Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?
Kundel Y; Brenner R; Purim O; Peled N; Idelevich E; Fenig E; Sulkes A; Brenner B
Dis Colon Rectum; 2010 Dec; 53(12):1624-31. PubMed ID: 21178856
[TBL] [Abstract][Full Text] [Related]
86. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer.
de la Torre A; Ramos S; Valcárcel FJ; Candal A; Regueiro CA; Romero J; Magallón R; Salinas J; de las Heras M; Veiras C; Tisaire JL; Aragón G
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):629-34. PubMed ID: 10524415
[TBL] [Abstract][Full Text] [Related]
87. Phase I/II Study of Preoperative Chemoradiotherapy With TEGAFIRI for Locally Advanced Rectal Cancer.
Kawai K; Sunami E; Hata K; Tanaka T; Nishikawa T; Otani K; Sasaki K; Nozawa H
Clin Colorectal Cancer; 2018 Sep; 17(3):240-246. PubMed ID: 29934092
[TBL] [Abstract][Full Text] [Related]
88. [New treatment strategies for patients with primary non-resectable rectal cancer].
Pfeiffer P; Baatrup G; Jensen HA; Kronborg O
Ugeskr Laeger; 2006 May; 168(19):1857-60. PubMed ID: 16756802
[TBL] [Abstract][Full Text] [Related]
89. [A case of effective regimen of tegafur and uracil (UFT)/leucovorin (LV) plus irinotecan (CPT-11) for advanced rectal carcinoma with severe pelvic infiltration to be performed curative resection].
Toyooka M; Shoji Y
Gan To Kagaku Ryoho; 2007 Apr; 34(4):635-8. PubMed ID: 17431356
[TBL] [Abstract][Full Text] [Related]
90. [A case of unresectable colon cancer responding to oral leucovorin+oral tegafur/uracil].
Saito N; Ohata M; Ishii H; Ohori M; Tokura Y; Maruyama M; Furukawa T; Sato H
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1287-90. PubMed ID: 17687215
[TBL] [Abstract][Full Text] [Related]
91. Phase II trial of UFT activity in pretreated breast cancer patients.
Daniels M; Díaz-Rubio E; Guillem V; Montero JM; García-Conde J; Estapé J; Martín M; Herranz C; Ordoñez A; Galán A
Jpn J Clin Oncol; 1993 Dec; 23(6):363-5. PubMed ID: 8283790
[TBL] [Abstract][Full Text] [Related]
92. Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.
Nakagawa R; Inoue Y; Ohki T; Kaneko Y; Maeda F; Yamamoto M
World J Surg Oncol; 2017 May; 15(1):112. PubMed ID: 28566093
[TBL] [Abstract][Full Text] [Related]
93. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
94. A phase I study of combined UFT plus leucovorin and radiotherapy for pancreatic cancer.
Childs HA; Spencer SA; Raben D; Bonner JA; Newsome J; Robert F
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):939-44. PubMed ID: 10863063
[TBL] [Abstract][Full Text] [Related]
95. UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience.
González Barón M; Feliu J; Garcia Girón C; Espinosa J; Martinez B; Blanco E; Crespo MC; Ordóñez A; Espinosa E; de Castro J; Juárez F; Colmenarejo A
Oncology; 1997; 54 Suppl 1():24-9. PubMed ID: 8978581
[TBL] [Abstract][Full Text] [Related]
96. A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
Oki E; Murata A; Yoshida K; Maeda K; Ikejiri K; Munemoto Y; Sasaki K; Matsuda C; Kotake M; Suenaga T; Matsuda H; Emi Y; Kakeji Y; Baba H; Hamada C; Saji S; Maehara Y
Ann Oncol; 2016 Jul; 27(7):1266-72. PubMed ID: 27056996
[TBL] [Abstract][Full Text] [Related]
97. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
98. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
Gérard JP; Conroy T; Bonnetain F; Bouché O; Chapet O; Closon-Dejardin MT; Untereiner M; Leduc B; Francois E; Maurel J; Seitz JF; Buecher B; Mackiewicz R; Ducreux M; Bedenne L
J Clin Oncol; 2006 Oct; 24(28):4620-5. PubMed ID: 17008704
[TBL] [Abstract][Full Text] [Related]
99. Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.
Sadahiro S; Suzuki T; Tanaka A; Okada K; Saito G; Miyakita H; Ogimi T; Nagase H
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1077-1085. PubMed ID: 28417167
[TBL] [Abstract][Full Text] [Related]
100. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
Guillem JG; Díaz-González JA; Minsky BD; Valentini V; Jeong SY; Rodriguez-Bigas MA; Coco C; Leon R; Hernandez-Lizoain JL; Aristu JJ; Riedel ER; Nitti D; Wong WD; Pucciarelli S
J Clin Oncol; 2008 Jan; 26(3):368-73. PubMed ID: 18202411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
